Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Baxter

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Health Physics|August 1, 1985
Radon-222 and 222Rn progeny concentrations measured in an energy-efficient house equipped with a heat exchangerR F Holub, R F Droullard, T B Borak, et al.
Cardiovascular Research|May 1, 1996
Infarct limitation of the second window of protection in a conscious rabbit modelX M Yang, G F Baxter, R J Heads, et al.
Circulation|June 27, 2001
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxideM M Mocanu, H L Maddock, G F Baxter, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 13, 2018
α-Fluoroalcohols: Synthesis and Characterization of Perfluorinated Methanol, Ethanol and n-Propanol, and their Oxonium SaltsAmanda F Baxter, Jonas Schaab, Joachim Hegge, et al.
The Australasian Journal of Dermatology|April 8, 2004
Paraneoplastic immunobullous disease with an epidermolysis bullosa acquisita phenotype: two cases demonstrating remission with treatment of gynaecological malignancyAlexander J Chamberlain, Susan M Cooper, Jill Allen, et al.
British Journal of Pharmacology|December 9, 2016
AP39, a mitochondria-targeting hydrogen sulfide (H<sub>2</sub> S) donor, protects against myocardial reperfusion injury independently of salvage kinase signallingQutuba G Karwi, Julia Bornbaum, Kerstin Boengler, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 11, 2003
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel openingSavio P D'Souza, Derek M Yellon, Claus Martin, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct studyG F Baxter, S L Hale, T Miki, et al.
Journal of the American College of Cardiology|June 13, 2001
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardiumM T Jaberansari, G F Baxter, C A Muller, et al.
Progress in Retinal and Eye Research|April 5, 2026
Ophthalmic manifestations of mitochondrial disordersMegan F Baxter, Grace A Borchert, Emma L Blakely, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Health Physics|August 1, 1985
Radon-222 and 222Rn progeny concentrations measured in an energy-efficient house equipped with a heat exchangerR F Holub, R F Droullard, T B Borak, et al.
Cardiovascular Research|May 1, 1996
Infarct limitation of the second window of protection in a conscious rabbit modelX M Yang, G F Baxter, R J Heads, et al.
Circulation|June 27, 2001
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxideM M Mocanu, H L Maddock, G F Baxter, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 13, 2018
α-Fluoroalcohols: Synthesis and Characterization of Perfluorinated Methanol, Ethanol and n-Propanol, and their Oxonium SaltsAmanda F Baxter, Jonas Schaab, Joachim Hegge, et al.
The Australasian Journal of Dermatology|April 8, 2004
Paraneoplastic immunobullous disease with an epidermolysis bullosa acquisita phenotype: two cases demonstrating remission with treatment of gynaecological malignancyAlexander J Chamberlain, Susan M Cooper, Jill Allen, et al.
British Journal of Pharmacology|December 9, 2016
AP39, a mitochondria-targeting hydrogen sulfide (H<sub>2</sub> S) donor, protects against myocardial reperfusion injury independently of salvage kinase signallingQutuba G Karwi, Julia Bornbaum, Kerstin Boengler, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 11, 2003
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel openingSavio P D'Souza, Derek M Yellon, Claus Martin, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct studyG F Baxter, S L Hale, T Miki, et al.
Journal of the American College of Cardiology|June 13, 2001
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardiumM T Jaberansari, G F Baxter, C A Muller, et al.
Progress in Retinal and Eye Research|April 5, 2026
Ophthalmic manifestations of mitochondrial disordersMegan F Baxter, Grace A Borchert, Emma L Blakely, et al.
Pageof 21